/Investor DB

ShangBay Capital LLC — 2019 Investments

3 investments dated 2019 · listed companies and verified rows first · show all

Apexigenapexigen.comNov 2019

BiotechSan Carlos, US

Xiaodong Yang(President, CEO and Secretary)inOvid Trifan(Executive Officer)Amy Wong(Executive Officer)Francis Sarena(Chief Operating Officer)Frank Hsu(Chief Medical Officer)William Duke, Jr.(Chief Financial Officer)

Co-investorsEFung CapitalSVE Capital3E Bioventures CapitalDecheng CapitalSv Tech Ventures, Inc.Virtus Inspire Ventures

Apostleapostlebio.cominMay 2019

Apostle develops cell-free DNA (cfDNA) extraction and purification kits for genomics and molecular biology laboratories.

BiotechHealthtechMedical DevicesMenlo Park, US

Dongliang Ge(Executive Officer, Director)Wenqi (Wayne) Zeng(Founder)inDavid GeinXin Guo(Director)Bo Zhang(Executive Officer, Director)

BoardWilliam Dai(Director)in

Co-investorsStartXAmino Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Meditrina

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.